Amgen, Horizon accuse FTC of trying to dodge constitutionality challenge

The Federal Trade Commission is attempting to prevent an Illinois federal court from hearing arguments that its administrative proceedings violate the Constitution, Amgen and Horizon Therapeutics have said.

Unlock unlimited access to all Global Competition Review content